Sanofi
Antibodies against Clostridium difficile toxins and methods of using the same
Last updated:
Abstract:
Monoclonal antibodies, or antigen-binding fragments thereof, that bind to Clostridium difficile (C. difficile) toxin A or toxin B and methods of using the same to detect or treat C. difficile infections and/or C. difficile-associated disease.
Status:
Grant
Type:
Utility
Filling date:
29 Nov 2018
Issue date:
11 Jan 2022